Download Now: Exclusive Guide About India's Potentially Decade-Long $10 Trillion Bull Run...
Here is the latest financial fact sheet of AJANTA PHARMA. For more details, see the AJANTA PHARMA quarterly results and AJANTA PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.8 |
No. of shares | m | 125.92 |
1 Week | % | 5.8 |
1 Month | % | -0.8 |
1 Year | % | 70.9 |
52 week H/L | Rs | 2,355.1/1,240.6 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
AJANTA PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 1,422 | 1,544 | 1,883 | 1,614 | 1,426 | |
Low | Rs | 898 | 840 | 1,258 | 1,089 | 1,062 | |
Sales per share (Unadj.) | Rs | 235.6 | 296.6 | 334.0 | 391.1 | 297.2 | |
Earnings per share (Unadj.) | Rs | 44.4 | 53.6 | 75.6 | 83.4 | 46.7 | |
Diluted earnings per share | Rs | 30.7 | 37.1 | 51.9 | 56.6 | 46.7 | |
Cash flow per share (Unadj.) | Rs | 52.6 | 64.6 | 89.0 | 98.1 | 57.1 | |
Dividends per share (Unadj.) | Rs | 9.00 | 13.00 | 9.50 | 9.50 | 7.00 | |
Adj. dividends per share | Rs | 6.24 | 9.01 | 6.53 | 6.44 | 7.00 | |
Avg Dividend yield | % | 0.8 | 1.1 | 0.6 | 0.7 | 0.6 | |
Book value per share (Unadj.) | Rs | 257.2 | 297.8 | 346.1 | 382.1 | 269.1 | |
Adj. book value per share | Rs | 178.2 | 206.4 | 237.9 | 259.2 | 269.0 | |
Shares outstanding (eoy) | m | 87.25 | 87.25 | 86.53 | 85.42 | 125.91 | |
Price / Sales ratio | x | 4.9 | 4.0 | 4.7 | 3.5 | 4.2 | |
Avg P/E ratio | x | 26.1 | 22.2 | 20.8 | 16.2 | 26.6 | |
P/CF ratio (eoy) | x | 22.0 | 18.5 | 17.7 | 13.8 | 21.8 | |
Price / Book Value ratio | x | 4.5 | 4.0 | 4.5 | 3.5 | 4.6 | |
Dividend payout | % | 20.3 | 24.3 | 12.6 | 11.4 | 15.0 | |
Avg Mkt Cap | Rs m | 101,190 | 103,993 | 135,898 | 115,433 | 156,638 | |
Total wages/salary | Rs m | 4,307 | 4,856 | 5,483 | 6,458 | 7,851 |
AJANTA PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 20,554 | 25,879 | 28,897 | 33,410 | 37,426 | |
Other income | Rs m | 211 | 922 | 260 | 1,157 | 986 | |
Total revenues | Rs m | 20,765 | 26,801 | 29,157 | 34,567 | 38,413 | |
Gross profit | Rs m | 5,664 | 6,794 | 9,986 | 9,293 | 7,833 | |
Depreciation | Rs m | 721 | 957 | 1,161 | 1,253 | 1,308 | |
Interest | Rs m | 12 | 119 | 83 | 102 | 58 | |
Profit before tax | Rs m | 5,143 | 6,640 | 9,002 | 9,095 | 7,453 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 1,273 | 1,963 | 2,463 | 1,968 | 1,573 | |
Profit after tax | Rs m | 3,870 | 4,677 | 6,539 | 7,127 | 5,880 | |
Gross profit margin | % | 27.6 | 26.3 | 34.6 | 27.8 | 20.9 | |
Effective tax rate | % | 24.8 | 29.6 | 27.4 | 21.6 | 21.1 | |
Net profit margin | % | 18.8 | 18.1 | 22.6 | 21.3 | 15.7 |
AJANTA PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 13,005 | 17,811 | 22,178 | 22,645 | 28,252 | |
Current liabilities | Rs m | 4,984 | 7,455 | 8,388 | 6,474 | 11,393 | |
Net working cap to sales | % | 39.0 | 40.0 | 47.7 | 48.4 | 45.0 | |
Current ratio | x | 2.6 | 2.4 | 2.6 | 3.5 | 2.5 | |
Inventory Days | Days | 41 | 36 | 53 | 43 | 66 | |
Debtors Days | Days | 8 | 11 | 9 | 11 | 10 | |
Net fixed assets | Rs m | 16,053 | 17,909 | 18,912 | 19,323 | 18,707 | |
Share capital | Rs m | 175 | 175 | 174 | 172 | 253 | |
"Free" reserves | Rs m | 22,266 | 25,809 | 29,777 | 32,469 | 33,624 | |
Net worth | Rs m | 22,441 | 25,984 | 29,951 | 32,640 | 33,877 | |
Long term debt | Rs m | 7 | 7 | 16 | 16 | 13 | |
Total assets | Rs m | 29,058 | 35,720 | 41,090 | 41,968 | 47,047 | |
Interest coverage | x | 444.3 | 56.7 | 109.8 | 90.2 | 128.6 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | |
Return on assets | % | 13.4 | 13.4 | 16.1 | 17.2 | 12.6 | |
Return on equity | % | 17.2 | 18.0 | 21.8 | 21.8 | 17.4 | |
Return on capital | % | 23.0 | 26.0 | 30.3 | 28.2 | 22.2 | |
Exports to sales | % | 52.0 | 55.7 | 62.6 | 55.9 | 59.9 | |
Imports to sales | % | 10.2 | 6.3 | 8.0 | 11.0 | 11.5 | |
Exports (fob) | Rs m | 10,682 | 14,421 | 18,097 | 18,678 | 22,420 | |
Imports (cif) | Rs m | 2,102 | 1,642 | 2,315 | 3,662 | 4,293 | |
Fx inflow | Rs m | 10,682 | 14,421 | 18,097 | 18,678 | 22,420 | |
Fx outflow | Rs m | 2,102 | 1,642 | 2,315 | 3,662 | 4,293 | |
Net fx | Rs m | 8,580 | 12,778 | 15,782 | 15,016 | 18,127 |
AJANTA PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 3,745 | 4,568 | 5,763 | 5,617 | 7,918 | |
From Investments | Rs m | -2,228 | -2,244 | -2,824 | -741 | -5,596 | |
From Financial Activity | Rs m | -1,475 | -1,286 | -3,183 | -4,597 | -1,079 | |
Net Cashflow | Rs m | 43 | 1,037 | -244 | 279 | 1,243 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Mannalal B Agrawal | COMP SEC: Gaurang Shah | YEAR OF INC: 1979 | BSE CODE: 532331 | FV (Rs): 2 | DIV YIELD (%): 0.3 |
Read: AJANTA PHARMA 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare AJANTA PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.